Material Event (Form 8-K)

Item 8.01 Other Events

On August 28, 2025, Telomir Pharmaceuticals, Inc., completed its sale of a total of 1,550,000 shares of its common stock, no par value, in block sales to institutional investors, at an average price of $1.87 per share (a premium to the prior day's close), through its at-the-market equity offering facility (the "Offering"). Gross proceeds from the Offering totaled approximately $2.9 million, prior to deducting fees and expenses. The trades for the Offering were facilitated through Rodman & Renshaw, via the StockBlock platform. The Offering did not include any warrants.